Reclast IV infusion solution 5mg, manufactured by Asahi Kasei Pharma, contains Zoledronic acid hydrate. This injectable drug, with YJ code 3999423A4027 and standard 5mg 100mL 1 bottle, is a bisphosphonate used to treat osteoporosis, including in men and postmenopausal women, and Paget’s disease.
Reclast IV infusion solution 5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).